Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Interest Expenses (2023 - 2025)

Biofrontera has reported Interest Expenses over the past 3 years, most recently at $120000.0 for Q1 2025.

  • Quarterly results put Interest Expenses at $120000.0 for Q1 2025, down 91.56% from a year ago — trailing twelve months through Dec 2025 was $120000.0 (down 91.92% YoY), and the annual figure for FY2024 was $2.1 million, up 857.27%.
  • Interest Expenses for Q1 2025 was $120000.0 at Biofrontera, up from $55000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for BFRIW hit a ceiling of $1.4 million in Q1 2024 and a floor of $9000.0 in Q3 2024.
  • Median Interest Expenses over the past 3 years was $87500.0 (2024), compared with a mean of $298500.0.
  • Biggest five-year swings in Interest Expenses: crashed 61.54% in 2024 and later crashed 91.56% in 2025.
  • Biofrontera's Interest Expenses stood at $143000.0 in 2023, then crashed by 61.54% to $55000.0 in 2024, then skyrocketed by 118.18% to $120000.0 in 2025.
  • The last three reported values for Interest Expenses were $120000.0 (Q1 2025), $55000.0 (Q4 2024), and $9000.0 (Q3 2024) per Business Quant data.